Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer? by Aneta Cymbaluk-Płoska, Paula Gargulińska, Michał Bulsa, Sebastian Kwiatkowski, Anita Chudecka-Głaz, Kaja Michalczyk

Get full text

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer by Aneta Cymbaluk-Płoska, Karolina Chudecka, Anita Chudecka-Głaz, Katarzyna Piotrowska, Sebastian Kwiatkowski, Maciej Tarnowski

Get full text

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients by Aneta Cymbaluk-Płoska, Paula Gargulińska, Anita Chudecka-Głaz, Sebastian Kwiatkowski, Ewa Pius-Sadowska, Bogusław Machaliński

Get full text

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer by Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska, Bogusław Machaliński, Janusz Menkiszak, Agnieszka Sompolska-Rzechuła

Get full text

Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy by Anita Chudecka-Głaz, Aleksandra Strojna, Kaja Michalczyk, Sylwia Wieder-Huszla, Krzysztof Safranow, Edyta Skwirczyńska, Anna Jurczak

Get full text

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department – the follow-up at 1 year by Tomasz Nikodemski, Agnieszka Biskup, Aleksandra Taszarek, Małgorzata Albin, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Janusz Menkiszak

Get full text

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus by Anna Jagodzińska, Anita Chudecka-Głaz, Kaja Michalczyk, Ewa Pius-Sadowska, Sylwia Wieder-Huszla, Anna Jurczak, Bogusław Machaliński

Get full text